Latest
-
Legal Trouble for Senator Bob Menendez May Hurt Dems: The Kiplinger Letter
The Kiplinger Letter Menendez stepped down as chairman of the Senate Foreign Relations Committee but contends he will run for reelection in 2024.
The Kiplinger Letter -
President Biden Builds the Wall: The Kiplinger Letter
The Kiplinger Letter Democrats are divided on how to handle illegal border crossings, but roughly 65% of voters, on average, disapprove of Biden's handling of the issue.
The Kiplinger Letter -
Tech Giants Look to Curb AI's Energy Demands: The Kiplinger Letter
The Kiplinger Letter The expansion in AI is pushing tech giants to explore new ways to reduce energy use, while also providing energy transparency.
The Kiplinger Letter -
Now Might Be a Good Time To Renew Your Passport
The Kiplinger Letter The State Department credits an increase in staff and new technology with shrinking processing times.
The Kiplinger Letter -
White House Aims to Limit Access to Short-Term Health Plans
The Kiplinger Letter The Biden administration's draft rule would restore several Obama-era regulations.
The Kiplinger Letter -
New Employment Guidance Proposed on Hostile Work Practices
The Kiplinger Letter New guidelines for employers fueled by a sharp increase in employment discrimination lawsuits in 2023.
The Kiplinger Letter -
SEC Cracks Down on Misleading Fund Names and Greenwashing: The Kiplinger Letter
The Kiplinger Letter The SEC rules aim to crack down on so-called “greenwashing” — misleading or deceptive claims by funds that use ESG factors.
The Kiplinger Letter -
As Tensions Rise, U.S. Imports From China Shrink: The Kiplinger Letter
The Kiplinger Letter China now accounts for less than 13.5% of American imports from abroad.
The Kiplinger Letter -
15 Cancer Drugs Are in Short Supply: The Kiplinger Letter
The Kiplinger Letter The U.S. is working to address cancer drug shortages caused by manufacturing and supply chain woes.
The Kiplinger Letter
